Beyond the Congress Video Edits Brad Kahl_recap_#BeyondASH21recap

7:42

Beyond the Congress Video Edits John Leonard_recap_#BeyondASH21recap

5:15

Beyond the Congress Video Edits Sonali Smith_recap_#BeyondASH21recap

2:41

Beyond the Congress Video Edits Nitin Jain_recap_#BeyondASH21recap

3:07

Nicole Lamanna, MD; Columbia University Medical Center; 5Live #ASH20 Part 1

6:57

Key insights from the 2020 Annual Hematology meeting in Chronic Lymphocytic Leukemia

Nicole Lamanna, MD; Columbia University Medical Center; 5Live #ASH20 Part 2

4:23

Key insights from the 2020 Annual Hematology meeting in Chronic Lymphocytic Leukemia

Susan O'Brien, MD; University of California Irvine; 5Live #ASH20

5:12

Key insights from the 2020 Annual Hematology meeting in Chronic Lymphocytic Leukemia

Matthew Davids, MD, MMSc; Dana Farber Cancer Institute; 5Live #ASH20

6:38

Key insights from the 2020 Annual Hematology meeting in Chronic Lymphocytic Leukemia

The Expanding Role of BTK Inhibitors for the Treatment of Patients With Chronic Lymphocytic Leukemia (CLL)_Webcast_Matthew Davids, MD, MMSc

40:50

Othman Al-Sawaf, MD University Hospital, Cologne 5Live #ASCO20

3:48

Key Insights on Fixed-duration venetoclax-obinutuzumab for previously untreated patients with chronic lymphocytic leukemia: Follow-up of efficacy and safety results from the multicenter, open-label, randomized, phase III CLL14 trial

Lindsey Roeker, MD Memorial Sloan-Kettering Cancer Center 5Live #ASCO20

3:55

Key Insights on Impact of premature venetoclax (Ven) discontinuation/interruption on outcomes in relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL): Phase III MURANO study results